| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.64▼ | 1.65▼ | 1.68▼ | 2.00▼ | 2.48▼ |
| MA10 | 1.68▼ | 1.67▼ | 1.69▼ | 2.15▼ | 2.51▼ |
| MA20 | 1.68▼ | 1.74▼ | 1.89▼ | 2.47▼ | 2.82▼ |
| MA50 | 1.74▼ | 2.00▼ | 2.12▼ | 2.55▼ | 4.31▼ |
| MA100 | 1.93▼ | 2.15▼ | 2.23▼ | 2.80▼ | 5.60▼ |
| MA200 | 2.10▼ | 2.38▼ | 2.55▼ | 3.51▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.005▲ | -0.016▼ | -0.080▼ | 0.026▲ |
| RSI | 38.103▼ | 33.350▼ | 30.178▼ | 24.059▼ | 33.172▼ |
| STOCH | 14.615▼ | 28.205 | 12.845▼ | 23.267 | 32.664 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -114.349▼ | -128.546▼ | -92.808 | -287.901▼ | -234.677▼ |
|
Thursday, October 29, 2026 04:30 AM
Placebo-controlled results of RewinD-LB clinical trial published in Alzheimer’s Research & Therapy provides further evidence of the potential of neflamapimod to slow clinical disease progression in ...
|
|
Friday, October 23, 2026 02:13 PM
CervoMed Executive Matthew Winton Receives Stock Option Grant in October 2026. Per a Form 4 filed with the U.S. Securities and Exchange Commission, Matthew Winton, serving as Chie ...
|
|
Monday, October 05, 2026 03:53 AM
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $25.00 price target on CervoMed (NASDAQ: CRVO).The analyst commented: "Late ... This is a premium only article. To continue ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/10/26 | 1.71 | 1.77 | 1.60 | 1.60 | 585,339 |
| 29/10/26 | 2.17 | 2.18 | 1.66 | 1.75 | 1,105,691 |
| 28/10/26 | 2.21 | 2.27 | 2.14 | 2.21 | 199,859 |
| 27/10/26 | 2.215 | 2.30 | 2.18 | 2.22 | 150,558 |
| 26/10/26 | 2.29 | 2.29 | 2.18 | 2.24 | 103,966 |
| 23/10/26 | 2.23 | 2.33 | 2.22 | 2.31 | 111,783 |
| 22/10/26 | 2.29 | 2.35 | 2.23 | 2.24 | 97,663 |
| 21/10/26 | 2.31 | 2.41 | 2.31 | 2.34 | 79,257 |
| 20/10/26 | 2.28 | 2.4055 | 2.28 | 2.29 | 136,346 |
| 19/10/26 | 2.24 | 2.35 | 2.18 | 2.31 | 206,704 |
|
|
||||
|
|
||||
|
|